BRK.A vs. LLY: Berkshire Hathaway vs. Eli Lilly Stock Comparison

Company Profile

Berkshire Hathaway (BRK.A) is classified in the Financials sector (Financial Services), whereas Eli Lilly (LLY) belongs to Health Care (Pharmaceuticals, Biotechnology & Life Sciences) — their GICS classifications point to very different parts of the market.

Price Performance

Cumulative Growth

Trailing Returns

Calendar-Year Returns

Performance Metrics

Risk Profile

Drawdown History

Return Distribution

Risk Metrics

Eli Lilly (LLY) trades around 2.52M shares per day on average, while Berkshire Hathaway (BRK.A) sees only 206 — a volume gap that can matter for position sizing, exit liquidity, and order execution.

Risk-Adjusted Performance

Risk-Return Positioning

Risk-Adjusted Metrics

Profitability

Eli Lilly (LLY) at 86.02% sits in the top ROE quartile, while Berkshire Hathaway (BRK.A) at 12.12% is closer to the peer norm — stronger capital efficiency for LLY.

Eli Lilly (LLY) at 31.90% converts revenue to bottom-line profit above its industry’s benchmark range, while Berkshire Hathaway (BRK.A) at 22.30% keeps roughly the typical share for its industry.

Eli Lilly (LLY) at 53.66% operates in the top operating margin quartile, ahead of Berkshire Hathaway (BRK.A) at 32.56%, which runs around its industry’s norm.

Profitability Metrics

Growth

Eli Lilly (LLY) at 44.70% is around its peer norm for revenue growth, while Berkshire Hathaway (BRK.A) at -3.23% drops into the bottom quartile, signaling weaker demand or pricing momentum.

Eli Lilly (LLY) at 95.99% sits in the top EPS growth quartile, while Berkshire Hathaway (BRK.A) at -24.78% is in the bottom quartile, showing a clear gap in earnings momentum.

Growth Metrics

Financial Strength

Eli Lilly (LLY) shows current ratio of 1.39; Berkshire Hathaway (BRK.A) doesn’t get one — Financial Services balance sheets aren’t split into current and non-current buckets, so short-term liquidity there is judged through regulatory measures instead.

Eli Lilly (LLY) shows debt-to-equity ratio of 1.23; for Berkshire Hathaway (BRK.A) the ratio is set aside — in Financial Services, balance-sheet leverage is part of the business model itself, so capital-adequacy measures do the job this ratio does elsewhere.

Financial Strength Metrics

Dividends

Berkshire Hathaway (BRK.A) pays no dividend (yield 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile Eli Lilly (LLY) reports a yield of 0.49%, ranking against industry peers normally.

Berkshire Hathaway (BRK.A) pays no dividend (payout 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile Eli Lilly (LLY) reports a payout of 21.71%, ranking against industry peers normally.

Dividend Metrics

Valuation

Berkshire Hathaway (BRK.A) at 14.36 is near its industry’s usual P/E ratio, while Eli Lilly (LLY) at 43.95 sits in the richer quartile — LLY needs stronger growth or earnings quality to justify the premium.

On P/S ratio, both Berkshire Hathaway (BRK.A) at 3.18 and Eli Lilly (LLY) at 13.95 are priced roughly in line with their industries — neither looks cheap nor rich on a sales basis.

Berkshire Hathaway (BRK.A) at 1.72 sits near its industry’s typical P/B ratio, while Eli Lilly (LLY) at 29.96 prices above its benchmark range — LLY looks rich relative to book.

Valuation Metrics